This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
The Population Assessment of Tobacco and Health (PATH) Study is a rich data source for researchers. In that light, Westat’s Katy Edwards, PhD, and Jean Opsomer, PhD, will be leading the PATH Study Data User Workshop on August 14-15, 2023, to further the understanding and use of the PATH Study data files. Participants can attend either in-person in Ann Arbor, Michigan, or via Zoom. Edwards, a Senior Research Associate, has been working on the PATH Study for 7 years and brings her tobacco research expertise; Opsomer, a Vice President and Westat Senior Statistical Fellow, brings 25+ years of statistical expertise.
The workshop will be a combination of lecture, discussion, and exercises, and will use hands-on examples to help attendees better understand the PATH Study sample design and weighting. They will learn how to conduct longitudinal analyses to estimate change over time, as well as pseudo cross-sectional analyses to estimate prevalence.
The course, which is free, is designed for academic faculty and research professionals, as well as graduate students interested in tobacco regulatory science and/or prevention/translation research.
To attend, apply between April 10 to May 5, 2023. Enrollment is limited and admission to the workshop is competitive. For more information: 2023 ICPSR Summer Program Short Workshop Registration website.
The PATH Study is a collaboration between the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) and the Center for Tobacco Products (CTP), Food and Drug Administration (FDA). The PATH Study is a household-based, nationally representative, longitudinal cohort study of approximately 46,000 adults and youth (ages 12-17) in the U.S. The Study was launched in 2011 to inform the FDA’s regulatory activities under the Family Smoking Prevention and Tobacco Control Act that was signed into law in 2009.